Kiromic BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, net loss was USD 16.26 million compared to USD 27.66 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 USD | -25.00% | -11.15% | +165.52% |
1st Jan change | Capi. | |
---|---|---|
+165.52% | 3.97M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |